• Cardiogreen: From Vascular Dye to Immune PTT

  2026-09-09

  Cardiogreen (Indocyanine Green) connects vascular imaging, photodynamic therapy, and emerging immune-enabled phototherapy. This translational analysis separates established evidence from testable hypotheses and outlines how researchers can evaluate optical, apoptotic, and macrophage-mediated endpoints.

• 10074-G5 Workflow for c-Myc Cancer Research

  2026-09-09

  10074-G5 provides a practical pharmacological probe for disrupting c-Myc/Max dimerization, connecting pathway biology with apoptosis, cell-cycle, and motility assays. This workflow shows how to translate c-Myc findings from lymphoma models into biomarker-guided esophageal adenocarcinoma experiments while controlling for solubility, exposure, and model-specific responses.

• Ouabain: A Precision Probe for Cardiovascular Translation

  2026-09-09

  Ouabain is more than a classic cardiac glycoside: it is a selective Na+/K+-ATPase inhibitor that can convert ion transport into a tractable translational research variable. This article connects pump inhibition with calcium handling, microvascular physiology, and cardiovascular disease modeling. Building on recent evidence that endothelium-dependent hyperpolarization protects intestinal perfusion during colitis, it outlines how Ouabain can help researchers test whether Na+/K+-ATPase activity shapes vascular resilience, astrocyte calcium storage, and outcomes in heart failure animal models.

• Benzyl-activated Streptavidin Magnetic Beads for HBV Assays

  2026-09-08

  Build cleaner HBV entry and protein-interaction workflows with high-affinity biotin capture, rapid magnetic separation, and adaptable wash conditions. The same platform also supports purification, immunoprecipitation, screening, and nucleic-acid workflows when assay-specific controls are applied.

• Recombinant Annexin V for Apoptosis Detection

  2026-09-07

  Brumatti, Sheridan, and Martin present a practical bacterial-expression workflow for producing soluble polyhistidine-tagged annexin V, purifying it by nickel affinity chromatography, and labeling it with FITC. The method converts phosphatidylserine externalization into a rapid flow-cytometry or fluorescence-microscopy readout while emphasizing calcium dependence and the need to distinguish apoptosis from other forms of membrane injury.

• Vemurafenib: A Causal Lens on Melanoma Resistance

  2026-09-07

  Vemurafenib and PLX4032 provide a precise pharmacological lens for studying BRAF-driven melanoma biology. This article translates multi-omics resistance findings into practical, time-resolved assay strategies for proliferation, signaling, and xenograft research.

• ω-Agatoxin IVA TFA: From Cav2.1 to Translation

  2026-09-05

  A mechanistic and translational guide to using ω-Agatoxin IVA TFA as a selective Cav2.1 probe in neuronal calcium current recording, synaptic transmission research, and epilepsy models.

• TiO2 Sonodynamic Therapy for PCO and Ferroptosis

  2026-09-04

  Li and colleagues developed TiO2 nanoparticle-coated intraocular lenses activated by ultrasound to reduce posterior capsular opacification (PCO). Their cellular, molecular, transcriptomic, and rabbit-eye data indicate that reactive oxygen species, glutathione depletion, GPX4 reduction, and lipid peroxidation contribute to a ferroptosis-like mechanism.

• Bay 11-7821 Workflows for NF-κB Research

  2026-09-04

  Bay 11-7821, also known as BAY 11-7082, provides a practical chemical perturbation point for NF-κB, inflammatory signaling, apoptosis, and macrophage–T-cell studies. This guide connects reporter assays and tumor-cell workflows with the abscopal-effect findings of recent radiotherapy–immunotherapy research, while emphasizing controls and interpretation limits.

• Cytochalasin D for Corneal Nanoparticle Uptake

  2026-09-03

  Cytochalasin D helps separate actin-dependent nanoparticle internalization from simple particle association in human corneal epithelial cell assays. This workflow combines controlled cytoskeletal perturbation with particle-size and surface-chemistry comparisons for more interpretable ocular drug-delivery data.

• Influenza Hemagglutinin (HA) Peptide in Translation

  2026-09-03

  Translational biology depends on experimental systems that preserve mechanistic resolution while supporting reproducible protein analysis. This article connects the IDH1-R132H autopalmitoylation study with strategic HA-tag workflows, showing how a competitive elution reagent can strengthen construct validation, protein-interaction studies, and preclinical evidence chains.

• Maternal IL-17A and Neonatal GBS Risk

  2026-09-02

  A prospective mother–newborn study in Morocco links reduced maternal IL-17A, IL-1β, and IL-4 responses among GBS-colonized women with invasive neonatal GBS disease. Its paired clinical and ex vivo design positions IL-17A as a promising risk-stratification biomarker while highlighting TLR1/2-responsive immune function as a relevant experimental endpoint.

• Pol II Degradation and Transcription-Independent Cell Death

  2026-09-02

  The reference preprint separates the consequences of removing RNA polymerase II from those of simply suppressing transcription. Its central implication is that Pol II degradation can activate cell death through a mechanism that cannot be explained solely by loss of transcriptional output, prompting more careful experimental discrimination between polymerase depletion, transcriptional stress, and downstream death pathways.

• 2'3'-cGAMP: A Translational STING Control

  2026-09-01

  2'3'-cGAMP is more than a pathway activator: it is a mechanistic reference point for separating DNA sensing from STING execution. This thought-leadership guide connects its biochemical precision with experimental design, pathway inhibition, immunotherapy research, and translational decision-making.

• Doxycycline hyclate in MMP/BBB research

  2026-09-01

  Doxycycline hyclate provides a practical way to interrogate MMP-linked barrier injury, neuronal apoptosis, and vascular inflammation across coordinated in vitro and in vivo workflows. Its solubility options, established MMP-2/MMP-9 study benchmark, and broader antiviral and antimalarial research utility make it more versatile than a single-endpoint inhibitor.

8579 records 1/572 page Next 12345 下5页 Last page